Case details

Court: ded
Docket #: 1:13-cv-01104
Case Name: Alza Corporation et al v. Par Pharmaceutical Inc.
PACER case #: 52387
Date filed: 2013-06-19
Date terminated: 2014-09-09
Assigned to: Judge Richard G. Andrews
Case Cause: 35:145 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: Defendant
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Alza Corporation
Counter Defendant
 
Steven J. Balick
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Andrew Colin Mayo
(See above for address)
ATTORNEY TO BE NOTICED

Fitz B. Collings
(See above for address)
ATTORNEY TO BE NOTICED

James A. High
(See above for address)
ATTORNEY TO BE NOTICED

Lisa A. Schneider
(See above for address)
ATTORNEY TO BE NOTICED

Peter S. Choi
(See above for address)
ATTORNEY TO BE NOTICED

Tiffany Geyer Lydon
(See above for address)
ATTORNEY TO BE NOTICED
Janssen Pharmaceuticals Inc.
Counter Defendant
 
Steven J. Balick
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Andrew Colin Mayo
(See above for address)
ATTORNEY TO BE NOTICED

Tiffany Geyer Lydon
(See above for address)
ATTORNEY TO BE NOTICED
Par Pharmaceutical Inc.
Counter Claimant
 
Steven J. Fineman
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Eric A. Lindberg
(See above for address)
PRO HAC VICE
ATTORNEY TO BE NOTICED

Harold M. Storey
(See above for address)
PRO HAC VICE
ATTORNEY TO BE NOTICED

Katharine Lester Mowery
(See above for address)
ATTORNEY TO BE NOTICED

Michael J. Freno
(See above for address)
PRO HAC VICE
ATTORNEY TO BE NOTICED
Actavis Elizabeth LLC
Defendant
TERMINATED: 09/24/2013		 
Dominick T. Gattuso
Proctor Heyman Enerio LLP
300 Delaware Avenue, Suite 200
Wilmington, DE 19801
(302)472-7311
Fax: (302) 472-7301
Email: dgattuso@proctorheyman.com
TERMINATED: 09/24/2013
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Actavis Inc.
Defendant
TERMINATED: 09/24/2013		 
Dominick T. Gattuso
(See above for address)
TERMINATED: 09/24/2013
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Osmotica Kereskedelmi es Szolgaltato Kft
Counter Claimant
TERMINATED: 06/13/2014		 
John C. Phillips , Jr.
(See above for address)
TERMINATED: 06/13/2014
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Cynthia H. Sun
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED

Damon Gupta
(See above for address)
TERMINATED: 06/13/2014
PRO HAC VICE
ATTORNEY TO BE NOTICED

Megan C. Haney
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED

Peter J. Curtin
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED

Robert M. Teigen
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED

Theodore Chiacchio
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED

William A. Rakoczy
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED
Osmotica Pharmaceutical Corp.
Counter Claimant
TERMINATED: 06/13/2014		 
John C. Phillips , Jr.
(See above for address)
TERMINATED: 06/13/2014
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Megan C. Haney
(See above for address)
TERMINATED: 06/13/2014
ATTORNEY TO BE NOTICED
Norwich Pharmaceuticals Inc.
Defendant
TERMINATED: 10/25/2013		 
Richard L. Horwitz
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr.
P.O. Box 951
Wilmington, DE 19899-0951
(302) 984-6000
Email: rhorwitz@potteranderson.com
TERMINATED: 10/25/2013
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

David Ellis Moore
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr.
P.O. Box 951
Wilmington, DE 19899-0951
(302) 984-6000
Email: dmoore@potteranderson.com
TERMINATED: 10/25/2013
ATTORNEY TO BE NOTICED

Sami Sedghani
Email: ssedghani@wsgr.com
TERMINATED: 10/25/2013
PRO HAC VICE
ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2013-06-19 1 0 MOTION for Leave to File Complaint Under Seal - filed by Alza Corporation, Janssen Pharmaceuticals Inc. (rwc) (Additional attachment(s) added on 6/20/2013: (1) Cover Letter to Clerk) , (2) Civil Cover Sheet) (rwc). (Entered: 06/20/2013)
2013-06-19 2 0 [SEALED] COMPLAINT - filed against Actavis Elizabeth LLC, Actavis Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number #19260.) - filed by Alza Corporation, Janssen Pharmaceuticals Inc.(rwc) (Entered: 06/20/2013)
2013-06-19 3 0 REDACTED VERSION of 2 Complaint - filed by Alza Corporation, Janssen Pharmaceuticals Inc. (rwc) (Entered: 06/20/2013)
2013-06-19 4 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 06/20/2013)
2013-06-19 5 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/7/13. Date of Expiration of Patent: 7/31/17.Thirty Month Stay Deadline: 11/7/2015. (rwc) (Entered: 06/20/2013)
2013-06-19 6 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,798. (rwc) (Entered: 06/20/2013)
2013-06-19 7 0 Disclosure Statement pursuant to Rule 7.1 filed by Alza Corporation, Janssen Pharmaceuticals Inc. identifying Corporate Parent Johnson & Johnson for Alza Corporation, Janssen Pharmaceuticals Inc. (rwc) (Entered: 06/20/2013)
2013-06-19 8 0 ACKNOWLEDGMENT OF RECEIPT of Magistrate Consent Forms. (rwc) (Entered: 06/20/2013)
2013-06-20 9 0 ORDER - granting 1 Motion to Seal Complaint. Signed by Judge Sue L. Robinson on 6/20/13. (rwc) (Entered: 06/20/2013)
2013-06-20 10 0 EXHIBIT re 3 Redacted Document by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 06/20/2013)
2013-06-20 11 0 SUMMONS Returned Executed by Alza Corporation, Janssen Pharmaceuticals Inc.. Par Pharmaceutical Inc. served on 6/19/2013, answer due 7/10/2013. (Lydon, Tiffany) (Entered: 06/20/2013)
2013-06-20 12 0 SUMMONS Returned Executed by Alza Corporation, Janssen Pharmaceuticals Inc.. Actavis Elizabeth LLC served on 6/20/2013, answer due 7/11/2013. (Lydon, Tiffany) (Entered: 06/20/2013)
2013-06-27 13 0 MOTION for Pro Hac Vice Appearance of Attorney David T. Pritikin, Lisa A. Schneider, Jeffrey P. Kushan, Peter S. Choi, James A. High, Jr., and Fitz B. Collings - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) (Entered: 06/27/2013)
2013-06-27 14 0 AFFIDAVIT of Service for Complaint and Summons served on Actavis, Inc. on June 19, 2013, filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 06/27/2013)
2013-07-03 15 0 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to September 9, 2013 - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 07/03/2013)
2013-07-05 16 0 NOTICE of Appearance by Dominick T. Gattuso on behalf of All Defendants (Gattuso, Dominick) (Entered: 07/05/2013)
2013-07-05 17 0 STIPULATION for an Extension of Time to respond to the Complaint, by Actavis Elizabeth LLC, Actavis Inc., Par Pharmaceutical Inc.. (Gattuso, Dominick) Modified on 7/8/2013 (nms). (Entered: 07/05/2013)
2013-08-22 18 0 STIPULATION TO EXTEND TIME to Answer Complaint to September 9, 2013 - filed by Actavis Elizabeth LLC, Actavis Inc.. (Gattuso, Dominick) (Entered: 08/22/2013)
2013-08-22 19 0 NOTICE of Appearance by Katharine Crawford Lester on behalf of Par Pharmaceutical Inc. (Lester, Katharine) (Entered: 08/22/2013)
2013-08-22 20 0 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Freno and Harold M. Storey - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 08/22/2013)
2013-08-22 21 0 Disclosure Statement pursuant to Rule 7.1 filed by Par Pharmaceutical Inc. identifying Corporate Parent Par Pharmaceutical Companies, Inc. for Par Pharmaceutical Inc... (Fineman, Steven) (Entered: 08/22/2013)
2013-09-07 22 0 STIPULATION TO EXTEND TIME to Answer Complaint to September 23, 2013 - filed by Actavis Elizabeth LLC, Actavis Inc.. (Gattuso, Dominick) (Entered: 09/07/2013)
2013-09-09 23 0 STIPULATION TO EXTEND TIME move, answer or otherwise respond to the Complaint to September 16, 2013 - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 09/09/2013)
2013-09-09 24 0 ANSWER to 2 Complaint, COUNTERCLAIM against All Plaintiffs, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Fineman, Steven) Modified on 9/10/2013 (nms). Modified on 9/10/2013 (nms). (Entered: 09/09/2013)
2013-09-10 25 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,930,129; 6,919,373; . (Lester, Katharine) (Entered: 09/10/2013)
2013-09-20 26 0 MOTION for Pro Hac Vice Appearance of Attorney William O. Ferron, Jr. of Seed Intellectual Property Law Group PLLC - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 09/20/2013)
2013-09-23 27 0 STIPULATION of Dismissal as to Actavis, Inc. and Actavis Elizabeth LLC by Actavis Elizabeth LLC, Actavis Inc., Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 09/23/2013)
2013-09-24 28 0 ORDER Granting 27 Stipulation of Dismissal, filed by Actavis Elizabeth LLC, Actavis Inc., Janssen Pharmaceuticals Inc., Alza Corporation, (Actavis Elizabeth LLC and Actavis Inc. terminated). Signed by Judge Richard G. Andrews on 9/24/2013. (nms) (Entered: 09/24/2013)
2013-09-24 29 0 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 10/8/2013, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/24/2013. (nms) (Entered: 09/24/2013)
2013-10-01 30 0 STIPULATION TO EXTEND TIME to Respond to Answer and Counterclaims to October 7, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 10/01/2013)
2013-10-04 31 0 STIPULATION TO EXTEND TIME to Reply to Answer and Counterclaims to October 17, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 10/04/2013)
2013-10-04 32 0 PROPOSED Scheduling Order, by Alza Corporation, Janssen Pharmaceuticals Inc., Norwich Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Lydon, Tiffany) Modified on 10/4/2013 (nms). (Entered: 10/04/2013)
2013-10-04 33 0 Letter to The Honorable Richard G. Andrews from Tiffany Geyer Lydon regarding Proposed Joint Scheduling Order - re (32 in 1:13-cv-01104-RGA, 29 in 1:13-cv-01126-RGA) Proposed Order. (Lydon, Tiffany) (Entered: 10/04/2013)
2013-10-09 34 0 Official Transcript of Scheduling Conference held on 10-08-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/30/2013. Redacted Transcript Deadline set for 11/12/2013. Release of Transcript Restriction set for 1/7/2014. (lad) (Entered: 10/09/2013)
2013-10-16 35 0 STIPULATION TO EXTEND TIME for Plaintiffs to reply to Defendant's Answer and Counterclaims to October 24, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 10/16/2013)
2013-10-17 36 0 PROPOSED Scheduling Order, by Alza Corporation, Janssen Pharmaceuticals Inc., Norwich Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Lydon, Tiffany) Modified on 10/21/2013 (nms). (Entered: 10/17/2013)
2013-10-17 37 0 Letter to The Honorable Richard G. Andrews from Tiffany Geyer Lydon regarding Proposed Joint Scheduling Order - re (35 in 1:13-cv-01126-RGA) Proposed Order. (Lydon, Tiffany) (Entered: 10/17/2013)
2013-10-18 38 0 NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.'s Initial Disclosures by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 10/18/2013)
2013-10-18 39 0 NOTICE OF SERVICE of Initial Disclosures by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 10/18/2013)
2013-10-21 40 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s First Set of Requests for Production of Documents (Nos. 1-56) to plaintiffs by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 10/21/2013)
2013-10-22 41 0 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery due by 9/26/2014. Joint Claim Construction Brief due by 5/22/2014. A Markman Hearing is set for 6/5/2014, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/6/2015, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A Bench Trial is set for 3/16/2015, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. Case numbers 13cv1104-RGA and 13-1126-RGA are consolidated for all purposes. All filings shall be made in case number 13-1104-RGA (see Order for further details). Signed by Judge Richard G. Andrews on 10/22/2013. Associated Cases: 1:13-cv-01104-RGA, 1:13-cv-01126-RGA(nms) (Entered: 10/22/2013)
2013-10-22 42 0 ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 12/16/2013 at 10:00 AM EASTERN TIME before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/22/13. (cak) (Entered: 10/22/2013)
2013-10-23 43 0 STIPULATION TO EXTEND TIME to Respond to Answer and Counterclaims to October 31, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 10/23/2013)
2013-10-22 44 0 ORDER Setting ADR Teleconference: Plaintiffs' to initiate the call. A Telephone Conference is set for 12/16/2013 at 10:00 AM in Chambers before Judge Mary Pat Thynge. Signed by Judge Mary Pat Thynge on 10/22/13. Associated Cases: 1:13-cv-01104-RGA, 1:13-cv-01126-RGA(kjk) (Entered: 10/24/2013)
2013-10-24 45 0 STIPULATION of Dismissal as to Norwich Pharmaceuticals Inc. only, by Alza Corporation, Janssen Pharmaceuticals Inc., Norwich Pharmaceuticals Inc.. (Lydon, Tiffany) Modified on 10/25/2013 (nms). (Entered: 10/24/2013)
2013-10-25 46 0 ORDER Granting 45 Stipulation of Dismissal, filed by Janssen Pharmaceuticals Inc., Norwich Pharmaceuticals Inc., Alza Corporation, (Norwich Pharmaceuticals Inc. terminated, Attorney Richard L. Horwitz and David Ellis Moore terminated). Signed by Judge Richard G. Andrews on 10/25/2013. (nms) (Entered: 10/25/2013)
2013-10-25 47 0 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Documents and Things to Defendant Par Pharmaceutical, Inc. (Nos. 1-85) by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 10/25/2013)
2013-10-25 48 0 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Documents and Things to Defendants Osmotica Kereskedelmi es Szolgaltato KFT and Osmotica Pharmaceutical Corp. (Nos. 1-83) by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 10/25/2013)
2013-10-29 49 0 STIPULATION TO EXTEND TIME to submit a proposal on specific e-discovery issues to November 19, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 10/29/2013)
2013-10-29 50 0 STIPULATION TO EXTEND TIME for Osmotica to submit their Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery to November 5, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Haney, Megan) (Entered: 10/29/2013)
2013-10-29 51 0 NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery to Par Pharmaceutical, Inc. and Plaintiffs' Disclosures Pursuant to Paragraph 4 of the Delaware Default Standard for Discovery to Par Pharmaceutical, Inc. by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 10/29/2013)
2013-10-29 52 0 NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery to Osmotica Kereskedelmi es Szolgaltato KFT and Osmotica Pharmaceutical Corp. and Plaintiffs' Disclosures Pursuant to Paragraph 4 of the Delaware Default Standard for Discovery to Osmotica Kereskedelmi es Szolgaltato KFT and Osmotica Pharmaceutical Corp. by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 10/29/2013)
2013-10-29 53 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Initial E-Discovery Disclosures by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 10/29/2013)
2013-10-30 54 0 NOTICE OF SERVICE of Par Pharmaceutical Inc.'s and Defendant Osmotica Kereskedelmi Es Szolgaltato Kft's First Set of Joint Rule 33 Interrogatories (Nos. 1-10) by Osmotica Kereskedelmi es Szolgaltato Kft.(Haney, Megan) (Entered: 10/30/2013)
2013-10-30 55 0 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendant Par Pharmaceutical, Inc. (Nos. 1-8) by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 10/30/2013)
2013-10-30 56 0 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants Osmotica Kereskedelmi es Szolgaltato KFT and Osmotica Pharmaceutical Corp. (Nos. 1-8) by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 10/30/2013)
2013-10-30 57 0 STIPULATION to dismiss Par's counterclaims related to the '373 patent and the '129 patent by Alza Corporation, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc.. (Mayo, Andrew) (Entered: 10/30/2013)
2013-10-31 58 0 ORDER Granting 57 Stipulated Dismissal without prejudice regarding counterclaims directed to the '373 patent and the '129 patent are voluntarily dismissed without prejudice, filed by Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc., Alza Corporation. Signed by Judge Richard G. Andrews on 10/31/2013. (nms) (Entered: 10/31/2013)
2013-10-31 59 0 ANSWER to 24 Answer to Complaint, Counterclaim by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 10/31/2013)
2013-11-05 60 0 MOTION for Pro Hac Vice Appearance of Attorney Cynthia H. Sun - filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Attachments: # 1 Sun Pro Hac Certification)(Haney, Megan) (Entered: 11/05/2013)
2013-11-05 61 0 NOTICE OF SERVICE of Osmotica Kereskedelmi Es Szolgaltato Kft's and Osmotica Pharmaceutical Corp.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 11/05/2013)
2013-11-18 62 0 STIPULATION TO EXTEND TIME to submit a proposal on e-discovery issues to December 10, 2013 - filed by Alza Corporation, Janssen Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 11/18/2013)
2013-11-18 63 0 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Osmotica KFT's First Set of Requests for Documents and Things (Nos. 1-67) by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 11/18/2013)
2013-11-25 64 0 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Par Pharmaceutical Inc.'s First Set of Requests for Documents and Things (Nos. 1-56) by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 11/25/2013)
2013-11-25 65 0 NOTICE OF SERVICE of Defendants Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp.'s First Set of Individual Rule 33 Interrogatories (Nos. 1-5) by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 11/25/2013)
2013-11-25 66 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s First Set of Interrogatories (Nos. 1-2) to plaintiffs by Par Pharmaceutical Inc..(Fineman, Steven) (Entered: 11/25/2013)
2013-11-27 67 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Responses to Plaintiffs' First Set of Requests for Documents and Things (Nos. 1-85) by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/27/2013)
2013-12-02 68 0 NOTICE OF SERVICE of (1) Defendants Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp.'s Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-83); and (2) Defendants Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp.'s Objections and Answers to Plaintiffs' First Set of Interrogatories by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 12/02/2013)
2013-12-02 69 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatores (Nos. 1-8) by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 12/02/2013)
2013-12-02 70 0 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Par Pharmaceutical, Inc.'s and Defendant Osmotica Kereskedelmi es Szolgaltato KFT's First Set of Joint Rule 33 Interrogatories (Nos. 1-10) by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 12/02/2013)
2013-12-10 71 0 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Par Pharmaceutical, Inc. by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 12/10/2013)
2013-12-10 72 0 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Osmotica Kereskedelmi es Szolgaltato KFT and Osmotica Pharmaceutical Corp. by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 12/10/2013)
2013-12-10 73 0 STIPULATION and Order Concerning Protocol for Discovery of Electronically Stored Information by Alza Corporation, Janssen Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Lydon, Tiffany) (Entered: 12/10/2013)
2013-12-11 74 0 Letter to The Honorable Richard G. Andrews from John C. Phillips, Jr. regarding Protective Order Dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Phillips, John) Modified on 12/11/2013 (nms). (Entered: 12/11/2013)
2013-12-11 75 0 SO ORDERED Granting 73 Stipulation and Order Concerning Protocol for Discovery of Electronically Stored Information, filed by Osmotica Kereskedelmi es Szolgaltato Kft, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc., Alza Corporation, Osmotica Pharmaceutical Corp.. Signed by Judge Richard G. Andrews on 12/11/2013. (nms) (Entered: 12/11/2013)
2013-12-12 76 0 Letter to The Honorable Richard G. Andrews from Tiffany Geyer Lydon regarding Plaintiffs' response concerning protective order disputes. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Lydon, Tiffany) (Entered: 12/12/2013)
2013-12-17 77 0 ORDER: Counsel are to provide by separate private email their respective clients position regarding mediation and advise when mediation would be preferred, including a brief explanation why for both topics on or before January 31, 2014. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 12/17/13. (cak) (Entered: 12/17/2013)
2013-12-17 78 0 Official Transcript of Discovery Dispute held on 12-13-13 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/7/2014. Redacted Transcript Deadline set for 1/17/2014. Release of Transcript Restriction set for 3/17/2014. (lad) (Entered: 12/17/2013)
2013-12-19 79 0 PROPOSED Protective Order, by Alza Corporation, Janssen Pharmaceuticals Inc., Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp., Par Pharmaceutical Inc.. (Mayo, Andrew) Modified on 12/20/2013 (nms). (Entered: 12/19/2013)
2013-12-20 80 0 SO ORDERED Granting 79 Proposed Protective Order, filed by Osmotica Kereskedelmi es Szolgaltato Kft, Janssen Pharmaceuticals Inc., Par Pharmaceutical Inc., Alza Corporation, Osmotica Pharmaceutical Corp.. Signed by Judge Richard G. Andrews on 12/20/2013. (nms) (Entered: 12/20/2013)
2013-12-26 81 0 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Par Pharmaceutical, Inc.'s First Set of Interrogatories (Nos. 1-2) filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 12/26/2013)
2013-12-26 82 0 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp.'s First Set of Individual Rule 33 Interrogatories (Nos. 1-5) filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 12/26/2013)
2014-01-14 83 0 NOTICE OF SERVICE of Defendants Osmotica Kereskedelmi Es Szolgaltato Kft's and Osmotica Pharmaceutical Corp.'s Preliminary Invalidity Contentions Under Paragraph 4(d) of the District of Delaware Default Standard for Discovery filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 01/14/2014)
2014-01-14 84 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Initial Invalidity Contentions filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 01/14/2014)
2014-01-21 85 0 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Documents and Things to Norwich Pharmaceuticals, Inc. (Nos. 1-7); (2) Plaintiffs' First Set of Interrogatories to Actavis Inc. and Actavis Elizabeth LLC (Nos. 1-4); and (3) Plaintiffs' First Set of Requests for Documents and Things to Actavis Inc. and Actavis Elizabeth LLC (Nos. 1-13) filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Mayo, Andrew) (Entered: 01/21/2014)
2014-01-23 86 0 NOTICE OF SERVICE of Defendants Par Pharmaceutical, Inc.'s, Osmotica Kereskedelmi Es Szolgaltato KFT's and Osmotica Pharmaceutical Corp.'s Claim Construction Issue Identification filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 01/23/2014)
2014-01-24 87 0 NOTICE OF SERVICE of Plaintiffs' Identification of Disputed Claim Term Requiring Construction filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 01/24/2014)
2014-02-11 88 0 NOTICE of Subpoena to Dr. James M. Swanson by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp. (Attachments: # 1 Exhibit 1)(Haney, Megan) (Entered: 02/11/2014)
2014-02-13 89 0 Letter from Steven J. Fineman regarding Discovery Dispute Letter Dated February 13, 2014. (Attachments: # 1 Exhibit A-E)(Fineman, Steven) (Entered: 02/13/2014)
2014-02-14 90 0 [SEALED] Letter to The Honorable Richard G. Andrews from Tiffany Geyer Lydon regarding Plaintiffs' response to Defendants' February 13 letter regarding discovery dispute - re 89 Letter. (Attachments: # 1 Exhibit A)(Lydon, Tiffany) (Entered: 02/14/2014)
2014-02-14 91 0 NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.'s Proposed Claim Construction filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 02/14/2014)
2014-02-17 92 0 NOTICE OF SERVICE of Defendants Osmotica Kereskedelmi Es Szokgaltato Kft and Osmotica Pharmaceuticals, Inc.'s Proposed Claim Constructions filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 02/17/2014)
2014-02-17 93 0 NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 02/17/2014)
2014-02-19 94 0 Official Transcript of Discovery Dispute held on 02-18-14 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/12/2014. Redacted Transcript Deadline set for 3/24/2014. Release of Transcript Restriction set for 5/20/2014. (lad) (Entered: 02/19/2014)
2014-02-21 95 0 REDACTED VERSION of 90 Letter, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 02/21/2014)
2014-02-25 96 0 NOTICE OF SERVICE of Norwich's Objections and Responses to Plaintiffs' First Set of Requests for Documents and Things (Nos. 1-7) filed by Norwich Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 02/25/2014)
2014-02-26 97 0 STIPULATION TO EXTEND TIME to submit Joint Claim Construction Chart to March 4, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) Modified on 2/26/2014 (nms). (Entered: 02/26/2014)
2014-03-04 98 0 Joint CLAIM Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A (Chart), # 2 Exhibit B)(Lydon, Tiffany) Modified on 3/5/2014 (nms). (Entered: 03/04/2014)
2014-03-04 99 0 EXHIBITS c-E re 98 Joint Claim Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit C, # 2 Exhibit D, part 1, # 3 Exhibit D, part 2, # 4 Exhibit D, part 3, # 5 Exhibit E, part 1, # 6 Exhibit E, part 2, # 7 Exhibit E, part 3)(Lydon, Tiffany) Modified on 3/5/2014 (nms). (Entered: 03/04/2014)
2014-03-04 100 0 EXHIBITS F-I re 98 Joint Claim Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit F, part 1, # 2 Exhibit F, part 2, # 3 Exhibit F, part 3, # 4 Exhibit F, part 4, # 5 Exhibit G, # 6 Exhibit H, # 7 Exhibit I)(Lydon, Tiffany) Modified on 3/5/2014 (nms). (Entered: 03/04/2014)
2014-03-04 101 0 EXHIBITS J-N re 98 Joint Claim Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit J, part 1, # 2 Exhibit J, part 2, # 3 Exhibit J, part 3, # 4 Exhibit J, part 4, # 5 Exhibit K, # 6 Exhibit L, # 7 Exhibit M, # 8 Exhibit N)(Lydon, Tiffany) Modified on 3/5/2014 (nms). (Entered: 03/04/2014)
2014-03-04 102 0 EXHIBITS O-HH re 98 Joint Claim Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit O, # 2 Exhibit P, # 3 Exhibit Q, # 4 Exhibit R, # 5 Exhibit S, # 6 Exhibit T, # 7 Exhibit U, # 8 Exhibit V, # 9 Exhibit W, # 10 Exhibit X, # 11 Exhibit Y, # 12 Exhibit Z, # 13 Exhibit AA, # 14 Exhibit BB, # 15 Exhibit CC, # 16 Exhibit DD, # 17 Exhibit EE, # 18 Exhibit FF, # 19 Exhibit GG, # 20 Exhibit HH)(Lydon, Tiffany) Modified on 3/5/2014 (nms). (Entered: 03/04/2014)
2014-03-12 103 0 STIPULATION to file amended complaints and for amended case schedule, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Amended Complaint against Par, # 2 Exhibit A to Amended Complaint against Par ('798 Patent), # 3 Exhibit B to Amended Complaint against Par ('179 Patent))(Lydon, Tiffany) Modified on 3/13/2014 (nms). (Entered: 03/12/2014)
2014-03-13 104 0 [SEALED] EXHIBIT re 103 Stipulation, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Lydon, Tiffany) (Entered: 03/13/2014)
2014-03-13 105 0 REDACTED VERSION of 104 Exhibit to a Document by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Lydon, Tiffany) (Entered: 03/13/2014)
2014-03-13 106 0 MOTION for Pro Hac Vice Appearance of Attorney Damon Gupta - filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Attachments: # 1 Gupta Pro Hac Certification)(Haney, Megan) (Entered: 03/13/2014)
2014-03-14 107 0 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Par Pharmaceutical, Inc. regarding U.S. Patent No. 8,629,179 filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 03/14/2014)
2014-03-14 108 0 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp. regarding U.S. Patent No. 8,629,179 filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 03/14/2014)
2014-03-14 109 0 SO ORDERED As Amended re 103 Stipulation and Order to File Amended Complaints, and Extending Scheduling Dates, filed by Janssen Pharmaceuticals Inc., Alza Corporation (Reset Deadlines: Joint Claim Construction Brief due by 6/5/2014) (see Stipulation for further details). Signed by Judge Richard G. Andrews on 3/14/2014. (nms) (Entered: 03/14/2014)
2014-03-14 110 0 AMENDED COMPLAINT against Par Pharmaceutical Inc.- filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(nms) (Entered: 03/14/2014)
2014-03-14 111 0 [SEALED] AMENDED COMPLAINT against Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.- filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(nms) (Entered: 03/14/2014)
2014-03-14 112 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8629179; . (Lydon, Tiffany) (Entered: 03/14/2014)
2014-03-18 113 0 MOTION for Pro Hac Vice Appearance of Attorney Eric A. Lindberg - filed by Par Pharmaceutical Inc.. (Fineman, Steven) (Entered: 03/18/2014)
2014-03-21 114 0 NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery to Osmotica Kereskedelmi Es Szolgaltato Kft and Osmotica Pharmaceutical Corp. and Plaintiffs' Supplemental Rule 26(a)(1) Initial Disclosures filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 03/21/2014)
2014-03-21 115 0 NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery to Par Pharmaceutical, Inc. and Plaintiffs' Supplemental Rule 26(a)(1) Initial Disclosures filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 03/21/2014)
2014-03-21 116 0 REDACTED VERSION of 111 Amended Complaint by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Lydon, Tiffany) (Entered: 03/21/2014)
2014-03-24 117 0 NOTICE OF SERVICE of Defendants Par Pharmaceutical, Inc.'s, Osmotica Kereskedelmi es Szolgaltato KFT's and Osmotica Pharmaceutical Corp.'s Claim Construction Issue Identification filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Haney, Megan) (Entered: 03/24/2014)
2014-03-28 118 0 ANSWER to 110 Amended Complaint, COUNTERCLAIM against Alza Corporation, Janssen Pharmaceuticals Inc. by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Fineman, Steven) Modified on 3/31/2014 (nms). (Entered: 03/28/2014)
2014-03-28 119 0 [SEALED] ANSWER to 111 Amended Complaint with Jury Demand, Defenses, COUNTERCLAIM against Alza Corporation, Janssen Pharmaceuticals Inc. by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Phillips, John) Modified on 3/31/2014 (nms). (Entered: 03/28/2014)
2014-04-01 120 0 Amended Joint CLAIM Construction Statement, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit II (Chart), # 2 Exhibit JJ, # 3 Exhibits KK-MM, # 4 Exhibits NN-OO, # 5 Exhibits PP-TT)(Lydon, Tiffany) Modified on 4/2/2014 (nms). (Entered: 04/01/2014)
2014-04-04 121 0 REDACTED VERSION of 119 Answer to Amended Complaint, Counterclaim,, by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Phillips, John) (Entered: 04/04/2014)
2014-04-10 122 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Initial Invalidity Contentions For U.S. Patent No. 8,629,179 and Supplemental Invalidity Contentions For U.S. Patent No. 8,163,798 filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 04/10/2014)
2014-04-10 123 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s First Supplemental Objections and Responses to Plaintiffs' Interrogatories (Nos. 3-4) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 04/10/2014)
2014-04-11 124 0 NOTICE OF SERVICE of Defendants Osmotica Kereskedelmi Es Szolgaltato Kfts and Osmotica Pharmaceutical Corp.s Preliminary Invalidity Contentions for U.S. Patent No. 8,629,179 Under Paragraph 4(d) of the District of Delaware Default Standard for Discovery filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Phillips, John) (Entered: 04/11/2014)
2014-04-11 125 0 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) Modified on 4/14/2014 (nms). (Entered: 04/11/2014)
2014-04-11 126 0 OPENING BRIEF in Support re 125 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct, filed by Alza Corporation, Janssen Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 4/28/2014. (Attachments: # 1 Exhibit A1, # 2 Exhibit A2, # 3 Exhibit B1, # 4 Exhibit B2, # 5 Exhibit C1, # 6 Exhibit C2, # 7 Exhibit D1, # 8 Exhibit D2)(Lydon, Tiffany) Modified on 4/14/2014 (nms). (Entered: 04/11/2014)
2014-04-18 127 0 NOTICE OF SERVICE of Osmotica Kereskedelmi Es Szolgaltato KFT's and Osmotica Pharmaceutical Corp.'s Supplemental Objections and Answers to Plaintiffs' First Set of Interrogatories (Nos. 3-4) filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..(Phillips, John) (Entered: 04/18/2014)
2014-04-18 128 0 NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Defendant Par Pharmaceutical, Inc.'s and Defendant Osmotica Kereskedelmi es Szolgaltato KFT's First Set of Joint Rule 33 Interrogatories (Nos. 1-10) filed by Alza Corporation, Janssen Pharmaceuticals Inc..(Lydon, Tiffany) (Entered: 04/18/2014)
2014-04-24 129 0 ORDER Setting Mediation Conferences: Mediation conferences are scheduled in the above matters for September 26, 2014 with Judge Thynge as follows: 8:30 a.m. to 1:30 p.m. -- Alza v. Par, C. A. No. 13-1104-RGA; 2:30 p.m. to 7:30 p.m. Alza v. Osmotica, C. A. No. 13-1126-RGA. Counsel and the parties are to report to Courtroom 2B. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 4/24/14. Associated Cases: 1:13-cv-01104-RGA, 1:13-cv-01126-RGA(cak) (Entered: 04/24/2014)
2014-04-25 130 0 PROPOSED First Addendum to Protective Order, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) Modified on 4/28/2014 (nms). (Entered: 04/25/2014)
2014-04-28 131 0 SO ORDERED Granting 130 First Addendum to Protective Order. Signed by Judge Richard G. Andrews on 4/28/2014. (nms) (Entered: 04/28/2014)
2014-04-28 132 0 ANSWERING BRIEF in Opposition re 125 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct filed by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp..Reply Brief due date per Local Rules is 5/8/2014. (Phillips, John) (Entered: 04/28/2014)
2014-04-28 133 0 [SEALED] ANSWERING BRIEF in Opposition re 125 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct filed by Par Pharmaceutical Inc..Reply Brief due date per Local Rules is 5/8/2014. (Fineman, Steven) (Entered: 04/28/2014)
2014-04-28 134 0 [SEALED] DECLARATION of Katharine C. Lester, Esq. re 133 Answering Brief in Opposition, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18)(Lester, Katharine) Modified on 4/29/2014 (nms). (Entered: 04/28/2014)
2014-05-05 135 0 REDACTED VERSION of 133 Answering Brief in Opposition, by Par Pharmaceutical Inc.. (Fineman, Steven) Modified on 5/6/2014 (nms). (Entered: 05/05/2014)
2014-05-05 136 0 REDACTED VERSION of 134 Declaration of Katharine C. Lester, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibits 1-5, # 2 Exhibits 6-9, # 3 Exhibits 10-18)(Fineman, Steven) Modified on 5/6/2014 (nms). (Entered: 05/05/2014)
2014-05-08 137 0 REPLY BRIEF re 125 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 05/08/2014)
2014-05-16 138 0 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 05/16/2014)
2014-05-27 139 0 MEMORANDUM ORDER Granting 125 MOTION to Strike Defenses and Dismiss Counterclaims Alleging Inequitable Conduct, but with leave to amend within ten day. Signed by Judge Richard G. Andrews on 5/27/2014. (nms) (Entered: 05/27/2014)
2014-06-05 140 0 [SEALED] Joint Claim Construction Brief, filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) Modified on 6/10/2014 (nms). (Entered: 06/05/2014)
2014-06-05 141 0 [SEALED] Joint APPENDIX, Volume I of III re 140 Joint Claim Construction Brief, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-C, # 2 Exhibit D (part 1 of 3), # 3 Exhibit D (part 2 of 3), # 4 Exhibit D (part 3 of 3), # 5 Exhibit E (part 1 of 3), # 6 Exhibit E (part 2 of 3), # 7 Exhibit E (part 3 of 3), # 8 Exhibit F (part 1 of 4), # 9 Exhibit F (part 2 of 4), # 10 Exhibit F (part 3 of 4), # 11 Exhibit F (part 4 of 4), # 12 Exhibit G, # 13 Exhibit H, # 14 Exhibit I, # 15 Exhibit J (part 1 of 4), # 16 Exhibit J (part 2 of 4), # 17 Exhibit J (part 3 of 4), # 18 Exhibit J (part 4 of 4))(Mayo, Andrew) Modified on 6/10/2014 (nms). Modified on 6/10/2014 (nms). (Entered: 06/05/2014)
2014-06-05 142 0 [SEALED] Joint APPENDIX, Volume II of III re 140 Joint Claim Construction Brief, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit K, # 2 Exhibit L, # 3 Exhibit M, # 4 Exhibit N - R, # 5 Exhibit S - X, # 6 Exhibit Y - EE, # 7 Exhibit FF - II, # 8 Exhibit JJ, # 9 Exhibit KK - MM, # 10 Exhibit NN - OO)(Mayo, Andrew) Modified on 6/10/2014 (nms). (Entered: 06/05/2014)
2014-06-05 143 0 [SEALED] Joint APPENDIX, Volume III of III re 140 Joint Claim Construction Brief, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit PP - TT, # 2 Exhibit UU - VV, # 3 Exhibit WW (part 1 of 4), # 4 Exhibit WW (part 2 of 4), # 5 Exhibit WW (part 3 of 4), # 6 Exhibit WW (part 4 of 4), # 7 Exhibit XX - YY, # 8 Exhibit ZZ (part 1 of 3), # 9 Exhibit ZZ (part 2 of 3), # 10 Exhibit ZZ (part 3 of 3), # 11 Exhibit AAA - CCC)(Mayo, Andrew) Modified on 6/10/2014 (nms). (Entered: 06/05/2014)
2014-06-06 144 0 [SEALED] Amended ANSWER to 111 Amended Complaint with Jury Demand, and Counterclaims against Alza Corporation, Janssen Pharmaceuticals Inc. by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Attachments: # 1 Exhibit 1-2, # 2 Certificate of Service)(Phillips, John) Modified on 6/10/2014 (nms). (Entered: 06/06/2014)
2014-06-06 145 0 [SEALED] Amended ANSWER to 110 Amended Complaint, COUNTERCLAIM against Alza Corporation, Janssen Pharmaceuticals Inc. by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 10, # 5 Exhibit 11, # 6 Exhibit 12, # 7 Exhibit 13, # 8 Exhibit 14, # 9 Exhibit 15, # 10 Exhibit 17, Part 1, # 11 Exhibit 17, Part 2, # 12 Exhibit 19)(Fineman, Steven) Modified on 6/10/2014 (nms). (Entered: 06/06/2014)
2014-06-06 146 0 EXHIBITS re 145 Answer to Amended Complaint, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 16, # 8 Exhibit 18)(Fineman, Steven) Modified on 6/10/2014 (nms). (Entered: 06/06/2014)
2014-06-11 147 0 NOTICE OF SERVICE of Defendant's First Set of Requests for Admission filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/11/2014)
2014-06-13 148 0 PROPOSED Consent Judgment and Dismissal as to Osmotica Kereskedelmi es Szolgaltato Kft and Osmotica Pharmaceutical Corp., by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) Modified on 6/13/2014 (nms). (Entered: 06/13/2014)
2014-06-13 149 0 SO ORDERED Granting 148 Proposed Consent Judgment and Dismissal, filed by Janssen Pharmaceuticals Inc., Alza Corporation, Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp. (Osmotica Pharmaceutical Corp. and Osmotica Kereskedelmi es Szolgaltato Kft terminated). Signed by Judge Richard G. Andrews on 6/13/2014. (nms) (Entered: 06/13/2014)
2014-06-13 150 0 REDACTED VERSION of 145 Answer to Amended Complaint, Answer to Counterclaim,,,, by Par Pharmaceutical Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 10, # 5 Exhibit 11, # 6 Exhibit 12, # 7 Exhibit 13, # 8 Exhibit 14, # 9 Exhibit 15, # 10 Exhibit 17, # 11 Exhibit 19)(Lester, Katharine) (Entered: 06/13/2014)
2014-06-18 151 0 STIPULATION TO EXTEND TIME to Respond to Defendant Par Pharmaceutical, Inc.'s Amended Answer and Counterclaims (D.I. 145) to July 14, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) (Entered: 06/18/2014)
2014-06-20 152 0 REDACTED VERSION of 144 Answer to Amended Complaint, by Osmotica Kereskedelmi es Szolgaltato Kft, Osmotica Pharmaceutical Corp.. (Attachments: # 1 Exhibits 1-2)(Haney, Megan) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
2014-06-20 153 0 REDACTED VERSION of 140 Joint Claim Construction Brief, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
2014-06-20 154 0 REDACTED VERSION of 141 Appendix, Voolume I of III, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A - C, # 2 Exhibit D part 1, # 3 Exhibit D part 2, # 4 Exhibit D part 3, # 5 Exhibit E part 1, # 6 Exhibit E part 2, # 7 Exhibit E part 3, # 8 Exhibit F part 1, # 9 Exhibit F part 2, # 10 Exhibit F part 3, # 11 Exhibit F part 4, # 12 Exhibit G, # 13 Exhibit H, # 14 Exhibit I, # 15 Exhibit J part 1, # 16 Exhibit J part 2, # 17 Exhibit J part 3, # 18 Exhibit J part 4)(Mayo, Andrew) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
2014-06-20 155 0 REDACTED VERSION of 142 Appendix, Volume II of III, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit K, # 2 Exhibit L, # 3 Exhibit M, # 4 Exhibit N - R, # 5 Exhibit S - X, # 6 Exhibit Y - EE, # 7 Exhibit FF - II, # 8 Exhibit JJ, # 9 Exhibit KK - MM, # 10 Exhibit NN - OO)(Mayo, Andrew) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
2014-06-20 156 0 REDACTED VERSION of 143 Appendix, Volume III of III, by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit PP - TT, # 2 Exhibit UU - VV, # 3 Exhibit WW part 1, # 4 Exhibit WW part 2, # 5 Exhibit WW part 3, # 6 Exhibit WW part 4, # 7 Exhibit XX - YY, # 8 Exhibit ZZ, # 9 Exhibit AAA - CCC)(Mayo, Andrew) Modified on 6/20/2014 (nms). (Entered: 06/20/2014)
2014-06-25 157 0 [SEALED] NOTICE to Take Deposition of Alza Corporation and Janssen Pharmaceuticals, Inc. on August 27, 2014 filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/25/2014)
2014-06-27 158 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Second Set of Interrogatories (Nos. 3-4) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 06/27/2014)
2014-07-02 159 0 REDACTED VERSION of 157 Notice to Take Deposition, by Par Pharmaceutical Inc.. (Lester, Katharine) Modified on 7/2/2014 (nms). (Entered: 07/02/2014)
2014-07-08 160 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Third Set of Interrogatories (Nos. 5--6) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 07/08/2014)
2014-07-08 161 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Requests for Admission for the Authentication of Documents (Nos. 1--52) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 07/08/2014)
2014-07-10 162 0 STIPULATION TO EXTEND TIME for Plaintiffs to respond to Par's Amended Answer and Counterclaims extended through and including July 28, 2014 and the completion of fact discovery extended through and including October 27, 2014. to - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 07/10/2014)
2014-07-11 163 0 NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Second Set of Requests for Production (Nos. 57-72) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 07/11/2014)
2014-07-24 164 0 STIPULATION TO EXTEND TIME to Respond to Amended Answer and Counterclaims to August 11, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) (Entered: 07/24/2014)
2014-08-11 165 0 STIPULATION TO EXTEND TIME to Respond to Par's Amended Answer and Counterclaims to September 2, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 08/11/2014)
2014-08-12 166 0 STIPULATION to Amend Scheduling Order by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 08/12/2014)
2014-08-13 167 0 SO ORDERED Granting 166 Stipulation & Order To Extend Time, filed by Janssen Pharmaceuticals Inc., Alza Corporation (Reset Deadlines: Fact Discovery due by 11/25/2014: The Markman Hearing scheduled for 8/21/2014, is now reset for 9/18/2014, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews) (see Stipulation for further details). Signed by Judge Richard G. Andrews on 8/13/2014. (nms) Modified on 9/9/2014 (nms). (Entered: 08/13/2014)
2014-08-27 168 0 STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Par's Amended Answer and Counterclaims to September 9, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Mayo, Andrew) (Entered: 08/27/2014)
2014-09-08 169 0 STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Par's Amended Answer and Counterclaims to September 16, 2014 - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 09/08/2014)
2014-09-09 170 0 PROPOSED CONSENT JUDGMENT by Alza Corporation, Janssen Pharmaceuticals Inc.. (Lydon, Tiffany) (Entered: 09/09/2014)
2014-09-09 171 0 CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 9/9/2014. (nms) (Entered: 09/09/2014)
2014-09-10 172 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,798; 6,930,129; 6,919,373; 8,629,179. (Attachments: # 1 Judgment)(nms) (Entered: 09/10/2014)
2014-09-16 173 0 ORAL ORDER: The mediations in these matters scheduled for 2/28/14 at 8:30 am (CA 13-1104) and 2:30 pm (CA 13-1126) are cancelled. Ordered by Judge Mary Pat Thynge on 9/16/14. Associated Cases: 1:13-cv-01104-RGA, 1:13-cv-01126-RGA(cak) (Entered: 09/16/2014)